Pro Medicus recently published their annual financial report, revealing an overall profit from ordinary activities after tax at A$60.6 million.

This figure shows a substantial increase in profitability for the company compared with the A$44.4 million reported the previous fiscal year.

Additionally, the revenue generated from its contracts with customers rose to A$124.9 million, up from the A$93.5 million recorded in the previous period.

The company also announced the declaration of a final dividend amount of 17.0 AU cents per share.

Pro Medicus (ASX:PME) is a leading health imaging company specializing in radiology product research and development.